HLA-DRB1 Position 57 Is Associated with Age at Type 1 Diabetes Diagnosis Beyond Class II Susceptibility Burden
Background/Objectives: Whether age at type 1 diabetes (T1D) diagnosis reflects overall HLA class II epitope burden or additional sequence information remains unclear. We investigated whether HLA-DRB1 β57, a position in HLA-DR distinct from the established DQB1 β57 susceptibility position in HLA-DQ, contributes information about age at diagnosis beyond class II epitope burden. Methods: Phased DRB1–DQA1–DQB1 data were analysed in 97 early-onset T1D patients (EOT1D; ≤5 years) and 96 later-onset patients (LaOT1D; 8–30 years), recruited specifically within these age groups, and 169 controls from Portugal. Analyses included burden-adjusted multinomial models, complementary continuous-age regression, natural DRB1*04 sequence comparisons, and repeated nested cross-validation with independently tuned leave-one-position-out ablations; log loss was the primary cross-validation metric. Results: Epitope burdens distinguished T1D from controls but showed no statistically supported difference between EOT1D and LaOT1D. Adding DRB1 β57D improved multinomial fit (p = 2.28 × 10−8); the adjusted EOT1D-versus-LaOT1D relative risk ratio was 3.17 per copy (95% CI 1.65–6.09). DRB1 β57D dosage correlated inversely with age at diagnosis (ρ = −0.231; p = 0.0012) and was associated with diagnosis 2.28 years earlier per copy in the adjusted continuous-age model (95% CI −4.17 to −0.38; p = 0.0187). Expanded natural DRB1*04 comparisons involved β57, β71 and β86. Removing β57 increased cross-validated log loss by 0.0783 (Benjamini–Hochberg-adjusted q = 0.028) and reduced the area under the receiver operating characteristic curve from 0.6643 to 0.5134; no other removal survived correction in the primary patient comparison. Adjusted subgroup analyses did not establish an association after excluding *04:08/*04:05 carriers or among non-DR4 participants. Conclusions: Within this Portuguese cohort, DRB1 β57 contributed information about age at T1D diagnosis beyond the specified class II epitope burdens. These findings refine the previously observed DRB1*04 allele associations and warrant independent replication and functional investigation.
Authors
- Íris Caramalho (ORCID: https://orcid.org/0000-0003-2479-7846)
- Dário Ligeiro (ORCID: https://orcid.org/0000-0001-5306-3679)
- Ana Laura Fitas (ORCID: https://orcid.org/0000-0002-6667-7597)
- Carlos Penha‐Gonçalves (ORCID: https://orcid.org/0000-0001-7225-1907)
- Tiago Paixão (ORCID: https://orcid.org/0000-0003-2361-3953)
- Jocelyne Demengeot (ORCID: https://orcid.org/0000-0002-4761-614X)
- Paula Matoso (ORCID: https://orcid.org/0000-0002-2315-7460)
- Daniel Sobral (ORCID: https://orcid.org/0000-0003-3955-0117)
- Catarina Limbert (ORCID: https://orcid.org/0000-0002-7455-4538)
Institutions
- Champalimaud Foundation (PT)
- University of Lisbon (PT)
- Instituto de Medicina Tropical (PY)
- Hospital de Dona Estefânia (PT)
- National Institute of Health Dr. Ricardo Jorge (PT)
- Instituto Portugues do Sangue e da Transplantacao, IP (PT)
- Gulbenkian Institute for Molecular Medicine (PT)
- Centro de Sangue e da Transplantação de Lisboa Área Funcional do Sangue (PT)
- Comprehensive Health Research Centre (PT)
- Instituto Gulbenkian de Ciência (PT)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- Genes
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/genes17111460
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Foundation for the Study of Diabetes
- Fundação para a Ciência e a Tecnologia